Helix
San Mateo · Founded 2015
About Helix
Helix is the leading population genomics company working at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world's largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+™ assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research.
Company Facts
- Founded: 2015
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $403.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Jun 2021)
- Website: helix.com
- Phone: +380 382 777 747
Industries & Categories
Big Data, Bioinformatics, Biotechnology, Blockchain, Cryptocurrency
Social Profiles
Canonical: https://fsome.com/organization/helix-49199 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.